Crescent Biopharma Inc. share price logo

Crescent Biopharma Inc.

NASDAQ: CBIO

Small Cap

$15.02

+0.27

(+1.80%)

as on

Crescent Biopharma Inc. Stock Performance

as on July 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $14.52
    $15.36
    downward going graph

    3.33%

    Downside

    2.26%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $8.72
    $27.41
    downward going graph

    41.94%

    Downside

    82.49%

    Upside

    downward going graph

Crescent Biopharma Inc. share price movements today

Previous Close
$14.75
Open
$15.36
Volume
203.1K
Day's Low - High
$14.52 - $15.36
52 Week Low - High
$8.72 - $27.41

Crescent Biopharma Inc. Historical Returns

1 Month Return
-16.62 %
3 Month Return
-39.97 %
1 Year Return
+ 11.74 %
3 Year Return
+ 127.1 %
5 Year Return
-78.58 %

Crescent Biopharma Inc. Stock Fundamentals & Key Indicators

Check Crescent Biopharma Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$526.1M

EPS (TTM)

-2.4933

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-160.75%

Crescent Biopharma Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Crescent Biopharma Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Crescent Biopharma Inc. image
Crescent Biopharma Inc.
NA$526.1M-78.58%NA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$39.6B515.81%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$123.3B147.44%28.8235.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$70.9B15.93%16.5329.65%0.53%

Stock Returns calculator for Crescent Biopharma Inc. Stock including INR - Dollar returns

The Crescent Biopharma Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Crescent Biopharma Inc. investment value today

Current value as on today

₹1,27,319

Returns

₹27,319

(+27.32%)

Returns from Crescent Biopharma Inc. Stock

₹13,788 (+13.79%)

Dollar Impact

₹13,531 (+13.53%)

Indian Investors' Interest in Crescent Biopharma Inc. Stock

Search interest for Crescent Biopharma Inc. Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:12% versus previous 30 day period

Crescent Biopharma Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
-
-
30
10
1
Gross Profit
0
0
-
0
28
10
1
Operating Income
-9
-17
-14
-21
-25
-91
-24
EBITDA
-9
18
-14
-20
-24
-90
-23
Interest Expense
-
0
1
1
-
3
-
Depreciation
-
-
-
0
0
0
0
Income Before Tax
-9
-17
-15
-21
-24
-90
-23
Income Tax Expense
-
-
-
-
-
2
-
Net Income
-9
-17
-15
-21
-24
-92
-23
Net Profit Margin
-90786.40%
0.00%
0.00%
0.00%
-80.51%
-852.06%
-2240.90%

Crescent Biopharma Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2025
Total Revenue
0
10
1
0
0
10
Gross Profit
0
10
1
0
0
10
Operating Income
-31
-51
-63
-47
-39
-152
EBITDA
-31
-51
-63
-47
-39
-149
Interest Expense
-
-
-
-
-
2
Depreciation
-
-
-
-
-
0
Income Before Tax
-31
-51
-63
-46
-36
-151
Income Tax Expense
-
-
-
-
-
2
Net Income
-31
-51
-63
-46
-36
-153
Net Profit Margin
-171945.07%
-502.09%
-5468.98%
-62251.74%
-368994.20%
-1419.61%

Crescent Biopharma Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-10
-10
-2
-37
-15
-21
-24
-92
-23
Operating Cash Flow
-10
-8
19
-6
-10
-16
-17
-26
-8
Investing Cash Flow
0
0
0
0
-
0
0
-72
-8
Financing Cash Flow
0
0
0
41
-1
146
-1
178
-6
Change in Cash
-10
-8
-22
34
-12
130
-19
79
-24

Crescent Biopharma Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-33
-48
-57
-51
-63
-46
-36
-37
-149
Operating Cash Flow
-29
-43
-51
-39
-57
-46
-34
-31
-71
Investing Cash Flow
0
0
0
0
0
0
0
0
-72
Financing Cash Flow
113
129
0
18
10
4
28
0
322
Change in Cash
83
85
-51
-21
-46
-42
-6
-31
178

Global Institutional Holdings in Crescent Biopharma Inc.

Funds
Holdings
Vestal Point Capital LP
5.44%
Raymond James & Associates
0%
Cutler Group LP
0%
Vanguard Capital Management, LLC
2.91%
NEXTBio Capital Management LP
1.35%
See all

Insights on Crescent Biopharma Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 595.4% return, outperforming this stock by 468.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 384.5% return, outperforming this stock by 372.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, CBIO stock has moved down by -40.0%

About Crescent Biopharma Inc.

Crescent Biopharma, Inc., a biotechnology company, researches and develops cancer therapy candidates in the United States. Its pipeline includes CR-001, which is in Phase 3 clinical trial, a proprietary anti-PD-1/anti-VEGF bispecific antibody to treat solid tumors; and CR-002, and CR-003. The company has a strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. for the development and commercialization of oncology therapeutics. The company was formerly known as GlycoMimetics, Inc. The company was founded in 2024 and is headquartered in Waltham, Massachusetts.
OrganisationCrescent Biopharma Inc.
Headquarters300 Fifth Avenue, Waltham, MA, United States, 02451
IndustryBiotechnology
CEOMr. Joshua T. Brumm
E-voting on sharesClick here to vote

Key Management of Crescent Biopharma Inc.

Name

Title

Mr. Richard William Scalzo M.B.A.

Chief Financial Officer

Mr. Ryan Lynch

Senior VP of Finance, Treasurer & Chief Accounting Officer

Dr. Jan Pinkas Ph.D.

Chief Scientific Officer

Mr. Christopher Doughty

Chief Business Officer

Mr. Joshua T. Brumm

CEO & Director

Dr. Jonathan McNeill M.D.

President & COO

Dr. Ellie Im M.D.

Chief Medical Officer

Dr. Wenjie Cheng Ph.D.

Senior Vice President of Technical Operations

Ms. Barbara Bispham Hale J.D.

General Counsel & Corporate Secretary

Ms. Amy Reilly

Chief Communications Officer

FAQs

What is Crescent Biopharma Inc. share price today?

Crescent Biopharma Inc. share price today is $15.02 as on at the close of the market. Crescent Biopharma Inc. share today touched a day high of $15.36 and a low of $14.52.

What is the 52 week high and 52 week low for Crescent Biopharma Inc. share?

Crescent Biopharma Inc. share touched a 52 week high of $27.41 on and a 52 week low of $8.72 on . Crescent Biopharma Inc. stock price today i.e. is closed at $15.02,which is 45.20% down from its 52 week high and 72.25% up from its 52 week low.

What is Crescent Biopharma Inc.'s market capitalisation today?

Crescent Biopharma Inc. market capitalisation is $0.00T as on .

How to invest in Crescent Biopharma Inc. Stock (CBIO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Crescent Biopharma Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Crescent Biopharma Inc. Shares that will get you 0.0999 shares as per Crescent Biopharma Inc. share price of $15.02 per share as on July 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Crescent Biopharma Inc. Stock (CBIO) from India?

Indian investors can start investing in Crescent Biopharma Inc. (CBIO) shares with as little as ₹96.445 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹964.45 in Crescent Biopharma Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Crescent Biopharma Inc. share’s latest price of $15.02 as on July 21, 2026 at 1:29 am IST, you will get 0.6658 shares of Crescent Biopharma Inc.. Learn more about fractional shares .

What are the returns that Crescent Biopharma Inc. has given to Indian investors in the last 5 years?

Crescent Biopharma Inc. stock has given -78.58% share price returns and 29.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?